Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy

Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy

Feb 24, 2013
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-reports-omalizumab-significantly-improved-chronic-idiopathic-urticaria-symptoms-patients-who-failed-standard-therapy-0